Brivaracetam Injection
Product Images NDC 0121-1075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 0121-1075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Brivar Inj 1)

FDA Label Image

Figure 1 (Brivar Inj 2)

FDA Label Image

Vial For Brivaracetam Injection 5 mL (Brivar Inj 3)

Vial For Brivaracetam Injection 5 mL (Brivar Inj 3)
This text provides information about a pharmaceutical product labeled as Brivaracetam Injection in single-dose vials with a concentration of 50 mg per 5 mL. The storage instructions recommend keeping it at a controlled room temperature. The text also mentions the dosage information, advising to refer to the package insert, and emphasizes that the product is for intravenous use only. Additionally, it specifies that any unused portion should be discarded. The lot number and expiration date are also provided.*
FDA Label Image

Carton For Brivaracetam Injection (Brivar Inj 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.